University of Verona
Prof. Vincenzo Bronte, M.D., started his research career at University of Padova (Italy) and then moved to the Surgery Branch of National Institutes of Health (NIH, Bethesda, USA) in Dr. Restifo’s laboratory, where he was actively involved in cancer immunology and immunotherapy researches. During these years, Prof. Bronte was among the pioneers to define and characterize myeloid cells with immunoregulatory functions that are now called myeloid-derived suppressor cells (MDSCs) and whose activity can restrain the efficacy of novel immunotherapeutic drugs. After that experience abroad, Prof. Bronte returned to Italy at the University of Padova/Azienda Ospedaliera and Verona University. Prof. Bronte contributed to the characterization of the molecular and enzymatic pathways that control and drive the MDSC-dependent immunosuppressive programs. He is author of more than 150 articles published in peer-reviewed journals. His H-index is 70 (i10- index of 136) with an amount of about 26,528 citations by Google Scholar database. He was included in the list of Highly Cited Researchers for 2018 by Clarivate Analytics in the Immunology field. This list recognizes world-class researchers selected for their exceptional research performance, demonstrated by production of multiple highly cited papers that rank in the top 1% by citations for field and year in Web of Science.